Amicus Therapeutics Inc. buy Needham & Company LLC
Start price
18.09.25
/
50%
€7.20
Target price
18.09.26
€11.85
Performance (%)
18.06%
Price
05.12.25
€8.40
Summary
This prediction is currently active. The prediction currently has a performance of 18.06%. This prediction currently runs until 18.09.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | -1.754% | -1.754% |
| iShares Core DAX® | 0.760% | 1.149% |
| iShares Nasdaq 100 | 0.732% | 1.884% |
| iShares Nikkei 225® | 1.025% | -0.865% |
| iShares S&P 500 | -0.036% | 1.480% |
Comments by Needham___Company_LL for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat